fda warning letters compounded tirzepatide 2024 2025 Letter Breakdown: Sterility Failures, Subpotent GLP-1 Drugs, and a Compounding Pharmacy Operating Without Control FDA Sends Warning Letters to

Cummings JL, Tong G, Ballard C

Wegovy is the semaglutide brand that is FDA-approved for chronic weight management in adults (and some adolescents) who meet certain BMI and health criteria

Portion Mindfulness: Use mechanical restrictions, such as ESG or the Spatz3 Adjustable Gastric Balloon, to keep portion sizes small and sustainable

Patients with a history of diabetic retinopathy should be monitored by an ophthalmologist during semaglutide treatment

Semaglutide has been approved for use in managing type 2 diabetes (as in Ozempic), and it is available for weight loss in other forms (such as Wegovy)

Are Wegovy and Ozempic the same drug